Terug
Dagbereik
€ 203,86
€ 208,72
52-Weeksbereik
€ 120,72
€ 233,60
Volume
1.958.769
50D / 200D Gem.
€ 217,05
/
€ 182,52
Vorige Slotkoers
€ 206,40
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 31,2 | 0,3 |
| P/B | — | 2,9 |
| ROE % | — | 3,7 |
| Net Margin % | 0,7 | 3,8 |
| Rev Growth 5Y % | 8,2 | 10,0 |
| D/E | — | 0,2 |
Koersdoel Analisten
Hold
€ 252,33
+21.8%
Low: € 220,00
High: € 275,00
Forward K/W
20,0
Forward WPA
€ 10,31
WPA Groei (sch.)
+0,0%
Omzet Sch.
260 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 17,35
€ 16,88 – € 17,96
|
370 B | 1 |
| FY2029 |
€ 14,88
€ 14,48 – € 15,40
|
330 B | 1 |
| FY2028 |
€ 13,03
€ 11,84 – € 14,17
|
300 B | 5 |
Belangrijkste Punten
Revenue grew 8,19% annually over 5 years — modest growth
Earnings grew 83,22% over the past year
Generating 1,85B in free cash flow
P/E of 31,24 — premium valuation
PEG of 0,30 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 10,06%
Groei
Revenue Growth (5Y)
8,19%
Revenue (1Y)-1,87%
Earnings (1Y)83,22%
FCF Growth (3Y)-11,52%
Kwaliteit
Return on Equity
N/A
ROIC25,99%
Net Margin0,70%
Op. Margin1,02%
Veiligheid
Debt / Equity
N/A
Current Ratio0,94
Interest Coverage10,58
Waardering
P/E Ratio
31,24
P/B RatioN/A
EV/EBITDA23,84
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,87% | Revenue Growth (3Y) | 4,20% |
| Earnings Growth (1Y) | 83,22% | Earnings Growth (3Y) | 117,49% |
| Revenue Growth (5Y) | 8,19% | Earnings Growth (5Y) | 26,43% |
| Profitability | |||
| Revenue (TTM) | 222,58B | Net Income (TTM) | 1,56B |
| ROE | N/A | ROA | 2,94% |
| Gross Margin | 3,67% | Operating Margin | 1,02% |
| Net Margin | 0,70% | Free Cash Flow (TTM) | 1,85B |
| ROIC | 25,99% | FCF Growth (3Y) | -11,52% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,94 |
| Interest Coverage | 10,58 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 31,24 | P/B Ratio | N/A |
| P/S Ratio | 0,22 | PEG Ratio | 0,30 |
| EV/EBITDA | 23,84 | Dividend Yield | 0,01% |
| Market Cap | 48,76B | Enterprise Value | 54,24B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 222,58B | 226,83B | 204,98B | 181,33B | 162,47B |
| Net Income | 1,56B | 852,00M | 330,00M | -938,00M | 611,00M |
| EPS (Diluted) | 6,45 | 3,45 | 1,26 | -3,34 | 2,08 |
| Gross Profit | 8,17B | 7,41B | 6,89B | 6,48B | 6,78B |
| Operating Income | 2,28B | 1,24B | 752,00M | -607,00M | 472,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 53,12B | 45,12B | 43,35B | 43,88B | 44,45B |
| Total Liabilities | 55,76B | 48,33B | 46,31B | 44,58B | 42,66B |
| Shareholders' Equity | -2,78B | -3,21B | -2,96B | -709,00M | 1,79B |
| Total Debt | 9,35B | 5,61B | 5,18B | 5,81B | 6,72B |
| Cash & Equivalents | 3,87B | 5,13B | 4,08B | 4,72B | 3,41B |
| Current Assets | 36,37B | 34,88B | 33,74B | 32,94B | 31,05B |
| Current Liabilities | 38,90B | 35,64B | 33,74B | 30,55B | 27,62B |